NICE says the cost-effectiveness of the drug is uncertain, but Novartis says the decision denies patients access to […]

The £3.2-million study will investigate whether there are any genetic causes of ME

Around 4,000 men newly diagnosed with high-risk metastatic hormone-sensitive prostate cancer would have been eligible for treatment with […]

In trials Keytruda showed ‘meaningful efficacy’ with an objective response rate of 34%

AstraZeneca, Daiichi Sankyo working on Japanese supply deal for COVID-19 vaccine hopeful kblankenship Fri, 06/26/2020 – 08:07

Novartis gives up on Xiidra’s EU approval, endangering payoff from $3.4B Takeda buyout aliu Fri, 06/26/2020 – 09:58

‘No presents anymore’: Inside Novartis’ scheme to boost Lucentis sales in Greece esagonowsky Fri, 06/26/2020 – 10:31

Chasing GW’s Epidiolex, Zogenix finally wins FDA nod for rare childhood epilepsy drug Fintepla aliu Fri, 06/26/2020 – […]

Chiasma secures FDA approval for acromegaly pill Mycapssa years after near-catastrophic rejection kblankenship Fri, 06/26/2020 – 12:49

bmj;369/jun26_2/m2581/FAF1faBarry Ian Hoffbrand was a national leader in postgraduate medical education. From 1980 to 1994 he was editor […]